Effectiveness of Assisted Reproduction Techniques as an Answer to Male Infertility by Sandrine Chamayou & Antonino Guglielmino
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
5 
Effectiveness of Assisted Reproduction 
Techniques as an Answer to Male Infertility 
Sandrine Chamayou and Antonino Guglielmino 
Unità di Medicina della Riproduzione – Via Barriera del Bosco 
Sant’Agata Li Battiati (CT) 
Italy 
1. Introduction 
The assisted reproductive technologies (ART) are of huge help in the resolution of couple 
infertility especially for male factor. For an evaluation of male fertility, the semen exam is 
the first analysis requested. All the procedures for an objective exam and parameters of 
normality have been worldwide established and described in a manual written by the 
World Health Organization (WHO).  
In the application of ART to obtain the pregnancy of healthy children, there are different 
levels of invasiveness that take in account both male and female factors. For moderate 
alteration of semen values, the ART called intra uterine insemination (IUI) is easy to perform 
because fertilization occurs in vivo. In case of intermediate alteration of semen values, 
metaphase II oocytes are incubated in a solution of motile spermatozoa in a process called in 
vitro fertilization (IVF). One spermatozoon penetrates by itself the oocyte membranes and 
fertilizes it. The development of embryos generated in the laboratory is followed until 
embryos are in utero transferred or stored in liquid nitrogen. Intra-cytoplasmic sperm 
injection (ICSI) is a variation of IVF in which the fertilization process is assisted. The elective 
field of ICSI application is a severe male factor. ICSI can be performed with fresh or thawed, 
motile or immotile, ejaculated or surgically retrieved (microsurgical epididymal sperm 
aspiration-MESA, sperm aspiration from the epididymis-PESA or testicle-TESA) 
spermatozoa. Recently, a new technique called IMSI (morphologically selected sperm 
injection) was introduced in the clinically assisted reproduction. In this case, the 
spermatozoon to micro-inject in the ooplasm is accurately chosen according to its 
morphology and particularly to the number and volume of vacuoles in the head of the cell.  
Numerous studies related in vivo and in vitro ART outcomes with male infertility and semen 
characteristics. The aim of this chapter is to present the effectiveness of ART as an answer to 
male infertility according to semen alterations (number, motility, morphology), the 
extraction of the spermatozoa (ejaculated/surgically extracted) and the process it underwent 
(cryopreservation). Furthermore, it has to be underlined that spermatozoa cryopreservation 
combined with ART represents a huge opportunity of fertility preservation for cancer 
patients. The genetic analysis of cells from biopsied embryos produced after ICSI 
(preimplantation genetic diagnosis-PGD) is an alternative mode of reproduction for couples 
with high risk in the transmission of male genetic disorder. 
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2. Semen characteristics 
The semen analysis is the basic exam in the determination of male fertility or infertility as it 
has been early determined a positive correlation between normal semen parameters and 
male infertility potential (WHO, 1987, 1992). 
The semen is a mixture of spermatozoa suspended in secretions from the testis and 
epididymis which are combined with seminal liquid. The seminal liquid is secreted in 90% 
by the prostate and the seminal vesicles, and a small proportion is secreted by bulb urethral 
glands. The final semen is a viscous fluid that comprises the ejaculate. The total number of 
spermatozoa reflects the sperm production by the testes and the patency of the post-
testicular duct system. The volume of the sample, produced by the accessory glands reflect 
the secretary activity of the glands. Other important parameters of the sperm function are 
represented by the vitality, the motility, the morphology and composition of the semen. The 
semen analysis must be standardized and objective. To emphasize the standardization of 
analysis procedures and to establish reference values, the WHO wrote a manual where the 
procedure of semen collection, analysis and the parameters of normality are described. 
Nowadays the fifth edition is available where the criteria of male infertility has been revised 
(WHO, 2010).  
2.1 Semen analysis 
This paragraph resumes the procedures for a correct semen collection and laboratory 
analysis as described by the WHO manual (2010). 
Commonly, the semen sample is obtain by masturbation. The semen sample should be 
collected after a minimum of 48 hours but no longer than seven days of sexual abstinence. 
The semen sample collection should be completed and two samples should be collected for 
initial evaluation within an interval of time that should not be less than 7 days or more than 
3 weeks. In case of markedly differences between two assessments, additional samples 
should be analyzed. 
The semen analysis is divided in macroscopic analysis and microscopic analysis.  
The macroscopic parameters are the semen aspect, the viscosity, liquefaction, the volume 
and the pH.  
The microscopic parameters are the sperm concentration calculated per millilitre (ml), the 
total number of spermatozoa per ejaculate, the percentage of motile spermatozoa, the sperm 
vitality, the agglutination of spermatozoa, the spermatozoa morphology and the presence of 
cellular elements other than spermatozoa. It is recommended to execute all microscopic 
examinations using a phase-contrast microscope.  
The semen analysis must be carried out on a fixed 20 um depth preparation. Depths  
less than 20 um constrain the rational movement of spermatozoa. Since sperm motility is 
highly dependent on temperature, the assessment of the motility should be performed  
at 37°C.  
The concentration of spermatozoa should be determined using the haemocytometer 
chamber as the ‘Newbauer haemocytometer’ on a diluted preparation of semen covered 
with a coverslip. The sperm count should be made of complete spermatozoa (heads  
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with tails). Defective spermatozoa (pinheads and tailless heads) should also be counted  
but recorded separately. If no spermatozoa is detected by microscopy, the entire  
sample should be centrifuged at 3000g for 15 minutes. If no spermatozoa is found after the 
complete analysis of the centrifuged sample, the semen is qualified as ‘azoospermic’.  
The total sperm number refers to the total number of spermatozoa in the entire  
ejaculate. This number is obtained by multiplying the sperm concentration by the semen 
volume.  
The grade of progressive motility of the spermatozoa is correlated with the pregnancy rate 
(Jouannet et al. 1988; Larsen et al. 2000; Zinaman et al. 2000). The sperm motility valuation 
should be performed close to the liquefaction of the sample, between 30 minutes and one 
hour after sperm collection. At least five microscopic fields are assessed in a systematic way 
to classify 200 spermatozoa. The motility of each spermatozoon is graded as ‘progressive’, 
‘non-progressive’, ‘immotile’, according to whether it shows:  
- Progressive motility (PR): spermatozoa moving actively, either linearly or in a large 
circle, regardless of speed;  
- Non progressive motility (NP): Swimming in small circles, the flagellar forces hardly 
displacing the head, or when only a flagellar beat can be observed;  
- Immotility (IM): no movement.  
The vitality is estimated by assessing the membrane vitality of the cells. It is routinely 
determined for the samples with less than 40% of progressively motile spermatozoa. The 
percentage of viable cells normally exceeds that of motile cells. The presence of a large 
proportion of vital but immotile spermatozoa may be indicative of structural defects in the 
flagellum (Cheme and Rawe, 2003); a high percentage of immotile and non-viable 
spermatozoa (necrozoospermia) may indicate epididymal pathology (Wilton et al. 1988; 
Correa-Perrez et al. 2004). 
The term of ‘Agglutination of spermatozoa’ means that motile spermatozoa stick to each 
other head-to-head, tail-to tail or in a mixed way, e.g. head-to-tail. The presence of 
agglutination is suggestive, but not sufficient evidence for, an immunological cause of 
infertility.  
The spermatozoa morphology is determined after cell staining. The most widely 
recommended staining recommended method used is the Papanicolaou stain. For a 
spermatozoa to be normal, the sperm head, neck, midpiece and tail must be normal. The 
head should be oval in shape. Allowing for the slight shrinkage induced by fixation and 
staining, the length of the head should be 4.0-5.0 um and the width 2.5-3.5 um. The length-
to-width ratio should be 1.50 to 1.75. There should be a well-defined acrosomal region 
comprising 40-70% of the head area. The midpiece should be slender, less than 1 um in 
width, about one and a half times the length of the head, and attached axially to the head. 
The morphological sperm defects should be noted as head defects, neck and midpiece 
defects, tail defects and cytoplasmic droplets. Abnormal spermatozoa generally have a 
lower fertilizing potential. Morphologically defects are associated with chromosomal 
abnormalities.  
In the microscopic analysis the non- nemaspermic cellular components are also valuated. 
There are referred as ‘round cells’ and compound of leukocytes, spermatogenic cells, 
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epithelium cells, red cells, prostate cells. A normal ejaculate should not contain more than  
5 x 106 round cells/ml.  
The semen analysis can be computer-assisted (Computeur-assisted semen analysis-CASA) 
(Yeung et al. 1997). The advantage of a computer assisted system for sperm analysis is the 
ability to obtain precise quantitative data as wells as the potential for the standardization of 
semen analysis procedures. Nevertheless, the main disadvantages are the lack of 
standardization procedures and the significant expense of equipment requirement. CASA is 
a valuable tool for research but the manual semen analysis remains the reference (Amann et 
al. 2004). Other tests can be made on semen such as the detection of sperm antibodies, sperm 
vitality, hypo-osmotic swelling test, assays of the sperm acrosome, sperm penetration assay, 
hemizona assay, mannose binding assay and assays of sperm DNA integrity and 
fragmentation. 
 
Fig. 1. Spermatozoon with normal morphology (a) and spermatozoa with vacuoles into the 
head (b). 
2.1.1 Reference values of semen analysis and semen variables 
Tables 1 and 2 summarise the lower references limits of semen characteristics as defined in 
the fifth edition of WHO manual, and the nomenclature of semen variables.  
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Parameter Lower reference limit 
Semen volume (ml) 1.5 (1.4-1.7) 
Total sperm number (106 per ejaculate) 39 (33-46) 
Sperm concentration (106 per ml) 15 (12-16) 
Total motility (PR+NP, %) 40 (38-42) 
Progressive motility (PR, %) 32 (31-34) 
Vitality (live spermatozoa, %) 58 (55-63) 
Sperm morphology (normal form, %) 4 (3.0-4.0) 
pH > 7.2 
Peroxidase-positive leucocytes (106 per ml) < 1.0 
MAR test (motile spermatozoa with  
bound particles, %) 
< 50 
Immunobead test (motile spermatozoa  
with bound beads, %) 
< 50 
Seminal zinc (umol/ejaculate) > 2.4 
Seminal fruttose (umol/ejaculate) > 13 
Seminal neutral glucosidase (mU/ejaculate) > 20 
Table 1. Lower reference limits of semen characteristics (5th centiles, 95% confidence 
intervals) 
 
Aspermia No ejaculate 
Asthenozoospermia Less than the reference value for motility 
Asthenoteratozoospermia 
Less than the reference values for motility and 
morphology 
Azoospermia No spermatozoa in the ejaculate 
Cryptozoospermia 
No spermatozoa is observed in the fresh preparation 
but only after centrifuged pellet 
Hemospermia (Hematospermia) Presence of leukocytes in the ejaculate 
Leukospermia (Leukocytospermia, 
pyospermia) 
Presence of leukocytes in the ejaculate above the 
threshold value 
Necrozoospermia 
Low percentage of live and high percentage of 
immotile spermatozoa in the ejaculate 
Normozoospermia Normal ejaculate as defined by the reference values 
Oligoastenoteratozoospermia 
Signifies disturbance of all three variables 
(concentration or total number, motility, 
morphology) 
Oligoteratozoospermia 
Less than the reference values for concentration or 
total number and morphology 
Oligozoospermia 
Sperm concentration (or total number) less than the 
reference value 
Teratozoospermia Less than the reference value for morphology 
Table 2. Nomenclature related to semen variations. 
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2.1.2 Sperm preparation techniques 
In a view to apply diagnostic tests of functions or to use the spermatozoa for therapeutic 
recovery for intra-uterine insemination (IUI) or in vitro ART, the spermatozoa must be 
separated from the seminal liquid. While the seminal liquid support the cervical mucus 
penetration in natural intercourse, the elimination of part of its compounds is necessary to 
perform IUI or in vitro fertilization (IVF). In the separation of spermatozoa from the seminal 
liquid, the final preparation concentrates morphologically normal and motile spermatozoa, 
free from debris, non-germ cells and dead spermatozoa. The separation and concentration of 
those spermatozoa is done performing a sperm preparation. Three methods are mainly 
used. The choice of a method is leaded by the semen characteristics. These methods are the 
simple washing, the direct swim-up and the density gradients. In all the sperm 
preparations, balanced salt solutions supplemented with proteins and containing an 
appropriate buffer are used as culture medium.  
The ‘Sperm washing’ is a simple sperm preparation, performed for good quality semen, 
often used for IUI. The principal is in the washing of the semen to remove the secretive part 
(WHO, 2010).  
The direct swim-up select the spermatozoa on their ability to swim out of the seminal liquid 
to the culture medium. It is the preferred method for the extraction of motile spermatozoa 
especially when their percentage is low e.g. for IVF and intracytoplasmic sperm injection 
(ICSI) (WHO, 2010).  
The discontinuous density gradient consists in the centrifugation of the semen on a column 
of colloidal silica coated with silane which separate the cells according to their density. 
Furthermore, the motile spermatozoa swim through the gradients and concentrate at the 
bottom of the tube. This method selects a high fraction of motile spermatozoa and is 
selective against the debris, the leukocytes, non-germ cells and degenerating germs cells. 
The discontinuous density gradient is mainly used for IVF and ICSI (WHO, 2010).  
If the patient is infected by the human immunodeficiency virus (HIV), the viral RNA and 
proviral DNA can be found in the seminal liquid and in non-sperm cells. In a view to 
prevent female partner contamination, a combination of density-gradient centrifugation 
followed by swim-up can be performed (Gilling-Smith et al. 2006; Savasi et al. 2007). With 
this combination of procedures, the motile spermatozoa are separated from the seminal 
liquid and virus-affected non-sperm cells.  
3. ART and results 
In the IUI practice, the female patient is monitored to determine the moment of ovulation; 
the semen is collected and prepared to select the best spermatozoa to transfer in utero. The 
fertilization process is in vivo. In IVF and ICSI protocols, the fertilization process is followed 
and in vitro assisted. Embryos are produced in the laboratory and are subsequently 
transferred in utero. 
3.1 IUI 
IUI is one of the earliest technique of assisted conception to be applied. It derives from intra-
cervical insemination in which the principle was to deposit a sample of semen (fresh or 
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thawed) into the vagina using a catheter. With the development of new sperm preparation 
and the separation of the motile spermatozoa from the secretive part (Mortimer, 1994), the 
IUI could be attempted. Concentrated preparation of sperm were attempted directly into the 
Fallopian tubes, peritoneal cavity, or ovarian follicles of the women, before to reach the 
consensus that IUI was the most effective method, providing a maximum pregnancy rate 
with a minimum of complications (Sacks and Simon, 1991). Although IUI can be performed 
in the natural cycle, nowadays it is combined with ovarian stimulation to increase the 
pregnancy rate.  
The clinical indications for IUI are couples with unexplained infertility, mild or moderate 
male-factor infertility. This technique can be applied in certain female factors infertility such 
as antisperm antibodies or hostile cervical environment. In case of male infertility, the 
presence of ten million of motile spermatozoa is a prerequisite but good results can be 
obtained with 5 and even one million of motile spermatozoa injected in uterus.  
From a technical point of view, on the day of IUI, the patient is asked to produce sperm into 
a sterile cup. After liquefaction and semen analysis, the sample is treated as previously 
described to select a high concentration of good motility spermatozoa. The final suspension 
of selected spermatozoa is concentrated in a maximal final volume of 500 ul of culture 
medium. IUI can be performed on natural cycle or on female patient that underwent a mild 
ovarian stimulation. Around the moment of pharmacologically monitored ovulation, the 
spermatozoa are deposited into the uterus without neither local anesthetic nor antibiotic 
prophylaxis using polyethylene catheter attached to a plastic syringe. After IUI, the female 
patient can resume normal activity.  
The success rates of IUI depends on the female patient age (De Sutter et al. 2005), the 
presence of comorbid conditions, ovulation method and the male factor (Burr et al. 1996). 
Abnormal spermatozoa morphology is associated with poor IUI outcomes on natural cycles 
and IUI with clomiphene or gonadotropin stimunation (Van Waart et al. 2001). Furthermore, 
abnormal sperm morphology has been associated with higher IUI complication rates such as 
miscarriage. Motility and concentration play also an important role in the pregnancy rate 
expectancy (Montanaro et al. 2001; Ombelet et al. 1997). Patients with percentage of a sperm 
motility superior to 30 percent have a four time increase cumulative pregnancy rate than 
patients with sperm motility less than 30 percent (Yalti et al. 2004). 
In conclusion, IUI is the most commonly performed ART procedure, a low cost technique 
and straightforward to perform.  
3.2 IVF 
The first world birth after IVF was obtained but Steptoe and Edwards in 1978 (Steptoe and 
Edwards, 1978). In 2006, it was estimated that more than three million of babies had been 
born using this procedure (ESHRE, 2006). The indications for IVF treatment include long-
standing infertility due to tubal disease, endometriosis, unexplained infertility, infertility 
involving male factor.  
The principle of IVF is the following: the female partner is given stimulatory drugs 
(gonadotrophin) in the weeks leading up to the procedure and in a view to trigger the 
development of several follicules. The follicular fluid  are collected in a tube and under 
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sedation. The follicular fluid is carefully read in the IVF laboratory and the oocytes that have 
grown inside the follicules are isolated and incubated. On the same day, the mature oocytes 
are incubated with an aliquot of fresh (or frozen) motile partner ‘spermatozoa. The test-
tubes or dishes containing the oocytes in the solution of spermatozoa are incubated up to 18 
hours at 37°C and 5% CO2. A reduced concentration of O2 (5-6%) can also be applied. 
Between 16 and 18 hours, the fertilization process is checked with the observation of two 
pronuclei. Tipically, between 60 and 70% of the oocytes are fertilized. In the following 
hours, a large majority of fertilized oocytes (now called ‘zygotes’) reach the embryo-stage 
with the first cell division. The embryo quality is evaluated on the base the number of cells 
according to the time of incubation, the absence of extra-cellular fragments, the capacity of 
the cells to compact at the morula stage and the blastocyst to expanse. The embryos can be 
maintained in in vitro culture until 5-6 days. Within this period, any embryo can be in utero 
transferred, discarded or frozen for a successive in utero transfer.  
Oehninger et al. (1988) studied the correlation between normal sperm morphology and 
insemination concentration. By increasing the insemination concentration in samples of 
severe teratozoospermia, the fertilization rate can be improved.  
The couples with male factor and undergoing conventional  IVF have a lower fertilization 
and pregnancy rate expectancy. On the same trend, very low pregnancy rates are obtained 
with surgical retrieved sperm (Hirsh et al. 1994). As a consequence and if a sufficient 
number of progressive motility spermatozoa is not available, the assisted reproductive 
technology called ‘Intra-cytoplasmic sperm injection’ (ICSI) must be applied as alternative 
and in a view to assist the fertilization process. The clinical pregnancy rate of IVF across 
Europe is 26.1% per egg collection and 29.6% per embryo-transfer (Andersen et al. 2007), 
although the success rates decrease according to female age over 35 (HFEA, 2005).  
 
Fig. 2. Embryo development. (a)Time of micro-injection: 0 hour (h); (b) zygote at 17+1 h; (c) 2 
cells at 23+1 h ; (d) 4 cells at 44+1 h; (e) 8 cells at 68+1h; (f) compacting morula at 92+2h; (g) 
blastocyst at 116+2h post ICSI or IVF. 
3.3 ICSI 
3.3.1 ICSI: History and indications 
On the process of micro-manipulation history that lead to ICSI, the techniques that were 
previously applied were the partial zona dissection (PZD) to facilitate the sperm penetration 
(Cohen et al. 1989), the subzonal insemination (SUZI) where the motile spermatozoa were 
micro-injected under the peri-vitelline space and were in direct contact with the oolemma 
(Laws-King et al. 1987). Subsequently ICSI of which the principle is the direct micro-injection 
of a single preferably with good morphology spermatozoon into the ooplasma was 
invented. The first pregnancies and births  was obtained in 1992 (Palermo et al. 1992). Since 
the beginning, ICSI appeared a superior technique due to higher resutls compared to SUZI 
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in terms of oocyte fertilization rate, number of embryos produced and implantation rates 
(Palermo et al. 1993; Van Steirteghem AC et al. 1993a; Van Steirteghem  et al. 1993b).  
ICSI can be applied in extremely low sperm counts, impair of motility, poor morphology 
(oligo-astheno-teratozoospermia) or azoospermia due to impaired testicular function or 
obstructed excretory ducts. ICSI can also be applied with non progressive motility or 
immotile spermatozoa. ICSI is the ultimate and only option for successful treatment of male 
infertility due to obstruction of the excretory ducts and impair of testicular functions.  
Table 3 shows the indications for ICSI. 
 
Ejaculated spermatozoa 
Oligozoospermia 
Asthenozoospermia (caveat for 100% immotile spermatozoa) 
Teratozoospermia (even globozoospermia and acrosomeless spermatozoa) 
High titers of antisperm antibodies 
Repeated fertilization failure after conventional IVF 
Autoconserved frozen sperm from cancer patients in remission 
Ejaculatory disorders (e.g. electroejaculation, retrograde ejaculation) 
Epidydimal spermatozoa 
Congenital bilateral absence of the vas deferens 
Young syndrome 
Failed vaso-epididymosotomy 
Failed vasovasostomy 
Obstruction of both ejaculatory ducts 
Testicular spermatozoa 
All indications for epididymal sperm 
Failure of epididymal sperm recovery because of fibrosis 
Azoospermia caused by testicular failure (maturation arrest, germ-cell aplasia) 
Necrozoospermia 
(Van Steirteghem, 2007)  
Table 3. Indications for clinical application of ICSI. 
The clinical pregnancy rates by use of ICSI are similar to those obtained with IVF, 26.5% of 
pregnancy rate according to egg collection and 28.7% according to embryo-transfer 
(Andersen et al. 2007). High fertilization and pregnancy rates can be obtained from motile 
spermatozoa (Nagy et al. 1995) while immotile and dead spermatozoa result in lower 
fertilization rate (Tournaye  et al. 1996). 
3.3.2 ICSI protocol 
As for the IVF procedure, the patient is stimulated and the follicle fluids containing mature 
(Metafase II) oocytes are aspirated. The retrieved oocytes are incubated in 5%CO2 at 37°C. 
The difference between IVF and ICSI lays in fertilization method. In a view to perform 
micro-injection, the cumulus and corona cells surrounding the oocytes must be removed 
using a combination of enzymatic and mechanical procedures. The assessment of the zona 
pellucida and the presence or absence of a germinal vesicle and of the first polar body are 
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verified at the microscopic observation. The presence and orientation of the meiotic spindle 
can be assessed when exposed to polarized light. 3.9% of the intact oocytes are at the 
metaphase I stage because they underwent germinal vesicle (GV) breakdown but they have 
not expelled the first polar; 10.3% of the intact oocytes are at the GV stage, and around 
85.8% of the intact oocytes are in the metaphase II stage, reaching the haploid stage and 
therefore available for micro-injection (Bonduelle et al. 1999). Matured, denuded and rinsed 
oocytes are incubated until the time of micro-injection. ICSI can be performed with 
spermatozoa that have been ejaculated, extracted from epipydimus or testis. As it has been 
described previously, the sperm is prepared to select motile and good morphology 
spermatozoa.   
The micro-injection of single spermatozoa inside the ooplasm is performed under an 
inverted microscope equipped with micro-manipulators, microinjectors and heating stage to 
maintain the temperature at 37°C. The magnification of 400X is recommended for the 
selection of moving spermatozoa. Micromanipulators give the possibility to move the two 
microinjectors in the 3 directions. The microinjectors can be filled with air or mineral oil and 
a micrometer controls the plunger. Generally, the holding is fixed to the microinjector on the 
left of the operator, and the injection pipette is fixed on the right. The oocyte can be fixed, 
positioned and released by the holding pipette, the spermatozoa is immobilized, injected 
and released using the injection pipette. It is recommended to position the microscope on a 
vibration-proof table.  
For the micro-injection setting, the gametes (metaphase II oocytes to be micro-injected and 
spermatozoa to micro-inject) are deposed within micro-droplets of buffered medium and on 
the same plastic micro-injection dish. The micro-droplets are covered by mineral oil. The 
micro-drop containing the spermatozoa is a mixture of spermatozoa plus PVP. The  
PVP slows down the spermatozoa motility and facilitates the manipulation and the control 
of the fluids. For ejaculated spermatozoa, they should be deposited on a single micro-drop, 
while extracted spermatozoa from testis or epididymis can be deposited on several micro-
droplets. Each denuded oocytes is placed on a single micro-drop-droplet (usually eight 
micro-droplets contain eight oocytes on the micro-injection dish). After the preparation of 
the dish with the gametes to use, the ICSI is performed. Step by step, ICSI can be described 
as follows: 
- the spermatozoa to micro-inject is chosen on the basis of its good morphology and 
motility.  
- The spermatozoa is immobilised using the injection pipette. Its immobilization is 
necessary to make the membrane permeable and to allow the release of sperm cytosolic 
factor which activates the oocyte (Palermo et al. 1993). For spermatozoa immobilization, 
the cell is positioned at 90° to the tip of the pipette, which is then lowered gently to 
compress the sperm flagellum. The shape of the tail should be maintained.  
- The immobilized psermatozoon is entered and maintained inside the micro-injection 
pipette by the flagellum. In other terms, the head is close to the way out of the 
micropipette. 
- The holding pipette is moved slowly to the oocyte. 
- The oocyte is held by the suction applied to the holding pipette.  
- The oocyte is slowly positioned: the polar body is at the 12 or 6 o’clock position. 
Nowadays, it is not the polar body that is taken in consideration as reference for oocyte 
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orientation but the meiotic spindle. During the oocyte denudation, the polar body can 
move within the peri-vitellin space. As a consequence, the position of the polar body 
could not correspond to the meiotic spindle position and the micro-injection can disturb 
the chromosomes alignment on the equatorial plane of the meiotic spindle and generate 
aneuploidies.  
- The oocyte is maintained in this position and the micro-injection pipette carrying the 
immobilized spermatozoa is moved slowly to the oocyte. 
- The spermatozoa is positioned at the end of the injection pipette. 
- The micro-injection pipette penetrates the zona pellucida and the ooplasma at the 3 
o’clock position. 
- The ooplasma is aspirated gently inside the micro-injection pipette until the observation 
of the sudden oolemma break.  
- The aspiration is immediately stopped.  
- The ooplasma is released from the micro-injection pipette and this way out movement 
is completed when the spermatozoon is completely released into the ooplasma.  
- The micro-injection pipette is slowly removed from the oocyte. 
- The oocyte is released from the holding pipette. 
When all of the oocytes of the dish have been microinjected, the dish is removed from the 
microscope and the oocytes are incubated in non-buffered medium in 5% of CO2 at 37°C.  
Differences in the oolemma breakage have been observed. The immediate break of the 
oolemma without any aspiration is associated with lower oocyte survival rates (Palermo et 
al. 1996).  
As in the IVF protocol, the fertilization process is checked 16-18 hours after micro- 
injection and embryo culture is prolonged until the destiny of each embryo is decided 
(transferred, frozen or discarded). As in IVF, abnormal fertilization can be observed with the 
formation of one pronucleus (about 3% of the micro-injected oocytes), and the finding of 
three pronuclear (3PN-about 4% of micro-injected oocytes) after the micro-injection of  
one single spermatozoon can be the consequence of extrusion failure of the second polar 
body at the time of fertilization (Staessen et al. 1997). No embryo generated from  
1PN and 3PN oocytes must be transferred. About 90% of the 2PN-oocytes cleave and 
become embryos.  
 
Fig. 3. Intracytoplasmic sperm injection procedure. The oocyte and the micro-injection pipette 
with the spermatozoon are positioned (a). The micro-injection pipette with the spermatozoon 
at its end goes through the zona pellucida, the peri-vitellin space (b) and penetrates the 
oolemma (c). The micro-injection pipette is removed after that the spermatozoon has been 
released into the ooplasma (d) (with the kind collaboration of C. Ragolia). 
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3.4 ICSI with surgical spermatozoa 
In patients that appear to be azoospermic after semen analysis, the surgical sperm retrieval 
is the last option to collect spermatozoa. The different techniques are percutaneous 
epididymal sperm aspiration (PESA), testicular sperm aspiration (TESA), testicular sperm 
extraction (TESE), and microsurgical epididymal sperm aspiration (MESA). The choice of 
the technique depends on the type of patient and of the diagnosis.  
In all surgical sperm retrieval, ICSI is the method of choice to obtain a pregnancy using fresh 
or frozen/thawed spermatozoa. 
3.4.1 PESA 
PESA is the least invasive surgical sperm retrieval technique. The patient is in conscious 
sedation and/or spermatic cord blockage with marcaine or lidocaine. The testis is 
immobilized and the aspiration is carried out with a 25-G butterfly needle. The fluid is 
aspirated and examined under microscope to check for motile spermatozoa. The recovered 
spermatozoa can be subsequently cryopreserved.  The percentage of motile spermatozoa 
retrieval is 93% (Ramos et al. 2004).  
3.4.2 TESA, TESE and micro-TESE 
Testicular sperm retrieval can be performed either on open surgical biopsy or as a 
percutaneous procedure. The term ‘Testicular sperm extraction’ (TESE) qualifies the open 
biopsy, and the term ‘testicular sperm aspiration’ (TESA) qualifies the percutaneous 
retrieval (Schlegel et al. 1998). The open surgical biopsy provides a higher quantity of tissue 
for harvesting spermatozoa than as aspiration procedure does. Nevertheless, TESA is 
generally sufficient for spermatozoa retrieval in patients with obstructive infertility and 
normal spermatogenesis. TESA is performed under local anesthesia. The transcutaneous 
aspiration uses a needle of 19-21 gauge directly into the testicular parenchyma and using 
negative pressure. In case of severely crompromised spermatogenesis, TESE should be the 
preferred method for harvesting spermatozoa.  
TESE is performed after spermatic cord anesthesia with marcaine and a transversal 1 cm 
incision through the scrotum and tunica vaginalis down to the tunica albuginea and tissue 
from the mid anterior surface of the testis.  
Microscopic TESE is a conjunction between open biopsy and it is conceptually similar to 
multibiopsy TESE, with the following differences: a single long testis incision is made to 
expose a large area of the testicular parenchyma and to access germ cells tubules, and a 
microscope is used to select the seminiferous tubules to be excised (Schlegel 1999). Since the 
number of spermatozoa obtained from micro-TESE is low, this procedure is generally 
performed the same day as eggs retrieval during ICSI.  
3.4.3 MESA 
The microsurgical epididymal sperm aspiration (MESA) is an advance in the therapy of 
non-reconstructable obstructive azoospermia (Schroeder-Printzen et al. 2000). The 
epididymis is exposed to a 12 mm incision made in the scrotal skin, an operating microscope 
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is used to identify and open the epidydimal tubule to carry out the epididymal sperm 
aspiration. In 90 percent of obstructive azoospermia cases, spermatozoa were retrieved from 
epididymis (Silber et al. 1990, Holden et al. 1997; Patrizio 2000). Nowadays this technique has 
been substitute by the less invasive PESA method.  
3.5 ICSI Results from surgical retrieved sperm 
The patients with obstructive azoospermia and non-obstructive azoospermia are 
successfully treated with ICSI using surgically retrieved spermatozoa from epididymis or 
testis. Numerous literature report ICSI with spermatozoa recovered from epididymis (Silber 
et al. 1994; Tournaye et al. 1994; Mansour et al. 1996) or testis (Schyosman et al. 1993; Silber et 
al. 1995). The fertilization and pregnancy rates from obstructive azoospermic patients are 
comparable to those obtained from patients with ejaculated sperm (Aboughar et al. 1997). In 
those patients, only the etiology can influence ICSI outcomes. The patients with acquired 
causes of obstructive azoospermia have higher fertilization (Nicopoullos et al. 2004a). The 
patients with non-obstructive azoospermia have a statistically significant decrease of 
fertilization and pregnancy rate when compared to osbstructive azoospermic patients 
(Nicopoullos et al. 2004b).  
3.6 IVF and ICSI results 
Beyond the male factor, the efficacy of all assisted reproductive technique is directly 
correlated with female age with a significant pregnancy expectancy over 40 years old 
(Oehninger et al. 1995; Devroey  et al. 1996).  
With ICSI, lower rated in terms of fertilization and pregnancy rates can be expected when 
no motile spermatozoa are available.  
It is now an overall consensus that the health of the children born from ART is the most 
important outcome parameter that has to be considered (Wennerholm et al. 2004). 
Pregnancy complications, major malformations, possible reasons for adverse outcome as 
well as the increase of multiple ART pregnancies must be taken under consideration. 
According to Jackson et al. (2004) and when compared to spontaneous conceived singleton 
children, the IVF and ICSI pregnancies are associated with higher odds of each perinatal 
mortality, pre-term delivery, low birth weight, very low birth weight and small gestation 
age. In twin pregnancies, the perinatal mortality is lower in assisted conception compared to 
spontaneous twins conceptions (Helmerhost et al. 2004). There is an overall increase for 
major congenital malformations after IVF and ICSI compared to spontaneously conceived 
children (Hansen et al. 2005) but no significant differences when IVF and ICSI are compared 
among them (Rimm et al. 2004). The possible causes of malformations are the abnormal 
caryotypes of infertile patients and properly in abnormal spermatozoa (Bonduelle et al. 
1999). A significative 2.1% of de novo anomalies are observed when sperm concentrations 
used for ICSI was below 20 million/ml (Bonduelle et al. 2002). It is possible that ART is 
associated with a higher risk of imprinting disorder, especially Angelman syndrome and 
Beckwith-Wiedemann syndrome. However, children born with ART are healthy and 
develop similar to children spontaneously conceived. General health, growth, and mental 
and psychomotor development of IVF children do not differ from spontaneously conceived 
children, even if lower birth weight and prematurity may contribute to some health 
problems observed (Ludwig et al. 2006).  
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3.7 IMSI 
The first findings on ICSI showed no influence of spermatozoa morphology on ICSI 
outcomes in terms of fertilization, embryo transfer and pregnancy rate (Hammadeh et al. 
1996; Svalander et al. 1996; Gomez et al. 2000). But successively, De Vos et al. (2003) 
underlined lower fertilization, pregnancy and implantation rates when the injected 
spermatozoa were morphologically abnormal. These data are supported by evaluating the 
aneuploidy rate in abnormal spermatozoa. The aneuploidy rates for chromosomes X, Y and 
18 was 29% in morphologically abnormal spermatozoa compared to 1.8%-5.5% in 
morphologically normal spermatozoa from the same sample (Ryu  et al. 2004).  
In 2002, the method of motile sperm organelle morphology examination was developed 
(MSOME-Bartoov et al. 2002). The examination is performed using an inverted microscope 
equipped with high-power Nomarski optics enhanced by digital imaging to achieve a 
magnification up to 6600X. The ICSI performed with a morphologically selected 
spermatozoa is called ‘intracytoplasmic morphologically selected spermatozoa’ (IMSI). In 
2009, Nadalini et al. reviewed the benefice of this technique on fertilization rate, embryo 
quality, implantation and pregnancy rates. Furthermore, the application of IMSI lead to a 
decrease of abortion rate and major congenital malformation (Berkovitz et al. 2007). As a 
consequence, the clinical application of IMSI technique highlights the early and late paternal 
effects on embryo development (Vanderzwalmen et al. 2008). Several studies showed that 
the correlation between morphologically abnormal head of the spermatozoa and incorrect 
DNA packaging (Berkowitz et al. 2005; Hazout  et al. 2006), DNA-protamine organization 
(Larson et al. 2000), DNA fragmentation (Franco et al. 2008), numerical and structural 
chromosome abnormalities (Calogero, 2003; Carrell et al. 2004).  
In conclusion, IMSI seems to improve in vitro results in selected group of patients with male 
factor infertility (Balaban et al. 2011). 
4. Sperm cryopreservation 
4.1 History and indications for sperm banking  
The history of human sperm cryobiology starts in the late 1940s with the discovery that 
glycerol protected the spermatozoa from freezing injury (Polge et al. 1949). In 1953, the first 
pregnancies were reported with the use of artificial insemination in combination with 
frozen-thawed sperm (Sherman and Bunge, 1953). Finally it was discovered that liquid 
nitrogen (LN2) leads to a better storage of human sperm with no subsequent loss of the 
motility when thawed after a long period of banking (Sherman, 1963).  
The semen cryopreservation has an important role in the male fertility preservation. 
Usually, the patients that undergo sperm banking are those that have a high risk in 
becoming infertile due to surgical or medical treatments such as chemo- or radiotherapy for 
cancer treatment but it is nowadays commonly used for areas of medicine that rely on the 
use of potentially cytotoxic drugs including treatments of progressive loss of muscular or 
neurological function, or for autoimmune conditions (Ranganathan et al. 2002). The 
oncological treatments can have detrimental effects on the gonad and preclude the survivors 
from having genetically related children. In these individuals, some degree of fertility can 
return post-treatment but it cannot be predicted. The incidence of azoospermia is high and 
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only 20 to 50 percent of these men eventually recover spermatogenesis (Shin et al. 2005). For 
these reasons, sperm banking is highly recommended for all patients with malignant disease 
that wish to preserve their fertility potential (Schover et al. 2002).  
Sperm banking can be applied before contraceptive measure (vasectomy), for precautionary 
measure of fertility because of high risk occupation or activity such as military forces, to 
prevent infertility due to surgeries for recurrent varicocele or hydrocele (Anger et al. 2003), 
or in a view to ensure a sample available the day of in vitro treatment. The patients that need 
special collection such as assisted ejaculated patients with spinal injury, spermatozoa from 
retrograde ejaculation in urine or surgical collection from the genital tract, found in sperm 
banking the possibility to cryopreserve spermatozoa for clinical and reproductive 
subsequent use.  
For all the patients that are at risk in losing the fertility due to pre-cited reasons, sperm 
banking gives a significant psychological support in the hope of future paternity. As a 
consequence, all males requiring chemo- or radiotherapy, including adolescents should 
have offered the possibility to store spermatozoa (Kamischke et al. 2004).  
Finally, sperm banking plays a crucial role in sperm donation programs.  
4.2 Sperm banking protocols and results 
The success of sperm cryopreservation depends on the maintenance of post-thaw structural 
and functional integrity. The compartments (i.e. acrosome, flagella, midpiece) of the 
spermatozoon must be protected in a view to undergo normal fertilization under either in 
vivo or in vitro conditions. Human spermatozoa are not very sensitive to damage caused by 
rapid initial cooling (cold shock) and they may be more resistant than other cells to 
cryopreservation damage because of their low water content (50%). Nevertheless, the post-
thaw motility of human spermatozoa can be ranged between 20 and 50 percent (Sbracia et al. 
1997). It is believed that the cause of this decrease could be multiple including diminished 
integrity of the membranes and cryodamage to the membranes of the intracellular 
compartments, which affects energy metabolism and synthesis.  
Pregnancy rates after IUI with cryopreserved donor semen are often related to sperm 
quality after thawing, timing of insemination and recipient factors such as age, previous 
pregnancy with sperm donor and ovulatory and uterine tubal disorders (Le Lannou and 
Lansac, 1993). If the semen is stored in appropriate conditions, no obvious deterioration of 
sperm quality should occur depending on the time of storage. Feldschuh et al. (2005) and 
Clarke et al. (2006) obtained children born after 28 years of sperm storage in liquid nitrogen.  
As a single spermatozoa is needed for each single oocyte to micro-inject, cryopreservation of 
any live spermatozoa is worthwhile. The assisted reproductive technique to apply for the 
research of pregnancy and using thawed semen depends on the quality of post-thaw semen 
parameters.  
Sperm cryopreservation is a complex process with a special responsibility and potential 
liability on the laboratory staff. The resources such as vessels, banks, storage room, liquid 
nitrogen containment and removal, the staff  safety and protection, the safety of sample 
storage in a view to ensure sterility, very stable conditions of temperature and to avoid the 
cross-contamination with infectious agents between samples in storage (e.g. transmission of 
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HIV, or hepatitis B or C via cryopreservation vessels) must be considered. The labeling and 
traceability of stored samples must be supported by written, validated  and applied 
procedures in a view to insure the safety of its clinical use.  
The common practice to obtain sperm to freeze is masturbation but surgical retrieved 
samples can also be frozen. Every freezing procedure is successive to a semen analysis that 
states the quality of the sample especially for spermatozoa concentration (and number) and 
motility. Nowadays, the human sperm storage can be performed in vapor phase or in direct 
contact with liquid nitrogen itself. The vapor phase may reduce the chances to cross-
contamination between siero-discordant samples but at the same time, it can be subject to 
large temperature gradients inside the vessels. In a view to ensure stable sample conditions, 
the temperatures should not go above -130°C. This condition must be ensured otherwise the 
direct contact with liquid nitrogen is more stable, safer and recommended for long period 
storage. Several freezing, sperm bank management protocols (Mortimer 2004; Wolf 1995) 
and cryoprotectants are available commercially. The WHO laboratory manual for the 
examination and processing of human semen details a home-made protocol of 
cryopreservation, storage and thawing of human spermatozoa for normozoospermic 
samples, oligozoospermic samples and surgically retrieved spermatozoa (WHO, 2010). The 
cryoprotectant used is glycerol-egg-yolk-citrate.  
In the freezing procedure the cryoprotectant is added in a proportion 1/2 to semen at 37°C. 
Successively, the mixture is incubated at 30-35°C for 5 minutes and filled in 0.5 ml plastic 
sterile straws or in cryovials. The straws are sealed. The cooling procedure can be performed 
in programmable freezer or manually. The common cooling program is to cool the straws at 
1.5°C per minute from 20°C to -6°C and then at 6°C per minute to -100°C. The chamber is 
than hold at -100°C for 30 minutes to allow the straws to be transferred to liquid nitrogen. In 
the manual method, the straws are placed at -20°C for 30 minutes, then placed at -70-79°C 
for 30 minutes and finally in liquid nitrogen (-196°C).  
The straws are placed in plastic storage tubes (mini-goblets) and inserted in large storage 
goblets within the bank in liquid nitrogen. At this stage, the straws can be transported in 
appropriate tanks and stable conditions of temperature. At the present time there is no limit 
of time for the storage of frozen sample.  
In the thawing procedure, the straws are removed from liquid nitrogen and placed at room 
temperature. Within 10 minutes, the straws (or cryovials) are opened and emptied. The 
post-thaw spermatozoa motility is valuated. The cryoprotectant is removed by washing 
procedures and the motile spermatozoa are available for clinical use.  
In case of oligozoospermic samples and surgically retrieved spermatozoa, the few motile 
spermatozoa can be frozen for subsequent ICSI previous centrifugation at 1500g to 
concentrate the few motile spermatozoa.  
Several samples can be frozen per patient, depending on the quality of the sample and the 
indication for sperm cryopreservation. As in the other procedures of ART, the identity and 
updated sierology of the patient must be confirmed at the beginning of each freezing set-up.  
In recent studies, Agarwal et al. (2004) reported the outcomes of ART according to the 
invasivity of the technique with thawed sperm in male cancer survivors. A total of 87 cycles 
were performed with the respective pregnancy rates: 7% after IUI, 23% after IVF and 37% 
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after ICSI. On the same way, Schmith et al. (2004) reported 14.8% after IUI and 38.6% after 
ICSI.  
Furthermore, there is no significant difference in quality between fresh and frozen-thawed 
epididymal or testicular spermatozoa in patients with obstructive azoospermia (Griffiths et 
al. 2004). The pregnancy rate from fresh and frozen-thawed spermatozoa extracted from the 
epididymis and testicular are similar among them (Nicopoullos et al. 2004b).  
5. ART and genetic male infertility 
In cases of male infertility due to severe non obstructive azoospermia or severe 
oligoastheteratozoospermia, a search for the karyotype for peripheral blood and 
microdeletions of AZF gene on Yp11 region should be performed.  
In infertile men, the Klineferter syndrome (47,XXY) is the most common genetic 
abnormality, which occurs in 1 of 500 live male births and is present in 13% of azoospermic 
pazients (Rucker et al. 1998). In these patients, spermatozoa can easily be found from 
surgically intervention and good fertilization rates have been reported (Staessen et al. 2003). 
Oligozoospermic patients can present autosomal chromosomal aberrations such as 
Robertsonian and reciprocal translocations (Yoshida et al. 1997).  
The prevalence of Y-chromosome microdeletions is 8% in infertile patients (Pagani et al. 
2002). These microdeletions are rare in patients with a spermatozoa concentration higher 
than 5 millions per ml. The male children of patients with microdeletions will carry the Y 
defect and it has been reported an association with Turner’s stigmata and sexual ambiguity 
(Patsalis et al. 2002).  
In patients with congenital bilateral absence of the vas deferens (CBAVD), mutations in the 
cystic fibrosis membrane conductance regulator gene (CFTR) should be evaluated. Cystic 
Fibrosis (CF) is the most common autosomal recessive disease in Caucasians with an 
incidence of 1 in 2500 and a carrier rate of 1 in 25. CF mutations is associated with CBAVD 
in 72% of the patients, and with Congenital Unilateral Absence of the Vas Deferens 
(CUAVD) and epididymal obstruction in respectively 30 and 34% of the patients (Mak et al. 
1999). In case of male carrier for CF mutations, the female patients must be screened prior to 
attempted ICSI and an appropriate genetic counseling must be given to the couple.   
Normally, fewer than 30 CAG repeats are present in the exon 1 of androgen receptor gene. 
The abnormal expansion of repeats would be due to failure in DNA to repair and lead to a 
severe neurodegenerative syndrome called Kennedy’s syndrome (Mak and Jarvi, 1996). 
Several studies have evidenced an increase of CAG repeats in normal men with idiopathic 
azoospermic (Yoshida et al. 1999) and in testicular tissue of infertile men (Maduro et al. 
2003). Consequently, the future generations may be concerned by accelerated expansion of 
instable DNA such as CAG repeats. 
The preimplantation genetic diagnosis (PGD) allows the couple at risk in the transmission of 
genetic defects such as chromosomal rearrangements (inherited chromosomal 
abnormalities), aneuploidy, X-linked diseases, autosomal single-gene disorders such as 
cystic fibrosis, haemoglobinopathies, Tay-Sachs disease to have an healthy child avoiding 
therapeutic abortion. Alternatives applications of PGD are for human leukocyte antigen 
(HLA) typing, nonmedical sex selection, genetic diseases with late onset. The principle  
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of PGD is the genetic analysis of a minimum of one embryo cells that should reflect the 
genetic embryonic inheritance. Only unaffected embryos are transferred in utero. PGD was 
applied clinically for the first time in 1990 (Handyside et al. 1990) and nowadays the ESHRE 
PGD Consortium gives updated data of PGD clinical application around the world (Harper 
et al. 2010). 
Imprinting of gene by methylation is an epigenetic phenomenon that regulates the gene 
expression. Cystidines located within dinucleotide CG repeated sequences are methyled 
into CpG islands lying outside the genes’coding regions. Imprinting occurs at different loci 
during gametogenesis and induces a gender-defined pattern of gene expression. At 
fertilization time, each gamete brings methylation patterns that are maintained in the 
offspring. If a failure of imprinting occurs during gametogenesis, two male or two female 
methylation pattern will be present at fertilization. This event is associated with spedific 
disease syndrome. In a recent study (Pacheco et al. 2011), CpG methylation profiles and 
mRNA alterations have been associated with low sperm motility. 
The frequency of imprinting disorders such as Beckwith-Wiedemann syndrome and 
Angelman syndrome are higher in children born after ICSI (Cox et al. 2002; De Baun et al. 
2003). The absolute risk is estimated at 1/3 000 for Beckwith-Wiedemann syndrome and 
1/20 000 for Angelman syndrome.  This data remains too low to be routinely screened of all 
ART children born (De Rycke, 2001).  
6. Conclusion 
A couple is considered infertile if no pregnancy is obtained after one year of unprotected 
intercourse. Infertility affects 15% of the couples. In 30% of the cases, pure female or pure 
male factor are the causes of infertility with an equal proportion. On a general point of view, 
the male factor is involved in half of the cases.  
In the treatment of couple infertility, it has been understood very early that ART would give 
a big help in reaching the pregnancy of an healthy child. Nowadays it is nearly impossible 
to calculate how many millions of children were born after assisted reproduction around the 
world.  
In the last decades, huge progresses have been made in helping the infertile male to become 
father, even in cases of very severe oligoteratoasthenozoospermia, azoospermia and 
carrying the risk of transmission of defective genetic trait. The sperm banking combined 
with ART plays a fundamental role in the preservation of male fertility for cancer patients.  
In any assisted reproductive technique proposed to the couple to resolve their infertility 
problem, the patients must be informed on medical procedure and all risks linked to the 
procedure. The most common risks are hyperstimulation (1-4% patients) and multiple 
pregnancies. Around 29% of all IVF and ICSI cycles results in twin gestation, and 5% results 
in three or more fetus (SART, 2004). Furthermore, an increasing rate of major congenital 
malformation has been observed after IVF and ICSI, mainly due to the causes of infertility. 
In the European Community, the donation, procurement, testing, processing, preservation, 
storage and distribution of reproductive cells and embryos are regulated in a view to 
guarantee the quality and the safety of their use and distribution (The European Parliament 
and the Council of the European Union, 2004) 
www.intechopen.com
 
Effectiveness of Assisted Reproduction Techniques as an Answer to Male Infertility 
 
125 
7. References 
Aboulghar MA, Mansour RT, Serour GI et al. (1997) Fertilization and pregnancy rates after 
intracytoplasmic sperm injection using ejaculated semen and surgically retrieved 
sperm. Fertility and Sterility, 68, 109-111 
Agarwal A, Ranganathan P, Kattal N et al. (2004) Fertility after cancer: a prospective review 
of assisted reproductive outcome with banked semen specimens. Fertility and 
Sterility, 81, 342-348 
Amann RP and Katz DF (2004) Reflections on CASA after 25 years. Journal of Andrology, 25, 
317-325  
Andersen AN, Goosens V, Gianaroli L et al. (2007) Assisted reproductive technology in 
Europe, 2003. Results generated from European registrers by ESHRE. Human 
Reproduction, 22, 1513-1525 
Anger JT, Gilbert BR and Goldstein M (2003) Cryopreservation of sperm: indications 
methods and results. Journal of Urology, 170, 1079-1084 
Balaban B, Yakin K, Alatas  et al. (2011) Clinical outcome of intracytoplasmic injection of 
spermatozoa morphologically selected under high magnification: a prospective 
randomized study, Reproductive BioMedicine Online, 22, 472-476 
Berkovitz A, Eltes F, Paul M et al. (2007) The chance of having a healthy normal child 
following intracytoplasmic morphologically-select sperm injection (IMSI) treatment 
is higher compared to conventional IVF-ICSI treatment. Fertility and Sterility,  
88, S20 
Berkovitz A, Eltes F, Yaari S et al. (2005) The morphological normalcy of the sperm nucleus 
and pregnancy rate of intracytoplasmic injection with morphologically selected 
sperm. Human Reproduction 20,185–190.  
Bartoov B, Berkovitz A, Eltes F, Kogosowski A, Menezo Y and Baraik Y (2002) Real-time fine 
morphology of motile human sperm cells is associated with IVF-ICSI outcomes, 
Journal of Andrology, 23(1), 1-8 
Bonduelle M, Camus M, De Vos A et al. (1999) Seven years of intracytoplasmic sperm 
injection and follow-up of 1987 subsequent children. Human Reproduction, 14(suppl 
1), 243-264 
Bonduelle M, Van Assche E, Joris H et al.  (2002) Prenatal testing in ICSI pregnancies: 
incidence of chromosomal anomalies in 1586 karyotypes and relation to sperm 
parameters. Human Reproduction, 17, 2600-2614 
Burr RW, Siegberg R, Flaherty SP, Wang XJ, Matthews CD (1996) The influence of sperm 
morphology and the number of motile sperm inseminated on the outcome of 
intrauterine insemination combined with mild ovarian stimulation. Fertility and 
Sterility, 65, 127-132 
Chemes HE, Rawe YV (2003) Sperm pathology: a step beyond descriptive morphology. 
Origin, characterization and fertility potential and abnormal sperm phenotypes in 
infertile men. Human Reproduction Update, 9, 405-428 
Clarke GN et al. (2006) Recovery of human sperm motility and ability to interact with the 
human zona pellucida after more than 28 years of storage in liquid nitrogen. 
Fertility and Sterility, 86, 721-722 
www.intechopen.com
 
Male Infertility 
 
126 
Cohen J, Malter H, Whright G et al. (1989) Partial zona dissection of human oocytes when 
failure of zona pellucid penetration is anticipated. Human Reproduction, 4(4), 435-
442 
Calogero AE (2003) Absolute polymorphic teratozoospermia in patients with oligo-
asthenozoospermia is associated with an elevated sperm aneuploidy rate. Journal of 
Andrology 24, 598–603 
Carrll DT, Emery BR, Wilcox AL et al. (2004) Sperm chromosome aneuploidy as related to 
male factor infertility and some ultrastructure defects. Archives of Andrology 50, 181–
185 
Correa-Perez et al. (2004) Clinical management of men producing ejaculates characterized by 
high levels of dead sperm and altered seminal plasma factors consistent with 
epididymal necrospermia. Fertility and Sterility, 81, 1148-1150 
Cox GF, Burger J, Lip V et al. (2002) Intracytoplasmic sperm injection may increase the risk if 
imprinting defects. American Journal of Human Genetics, 71, 162-164  
De Baun MR, Niemitz EL and Feinberg AP (2003) Association of in vitro fertilization with 
Beckwith-Wiedemann syndrome and epigenetic alteration of LIT1 and H19. 
American Journal of Human Genetics, 72, 150-160 
De Rycke M (2001) Epigenetics and ART. Infertility and assisted reproduction, Cambridge 
University Press, p677-683 
De Sutter P, Veldeman L, Kok P et al. (2005) Comparison of outcome of pregnancy  
after intra-uterine insemination (IUI) and IVF. Human Reproduction, 20, 1642- 
1646  
De Vos A, Van De Velde H. Joris H et al.  (2003) Influence of individual sperm morphology 
on fertilization, embryo morphology, and pregnancy outcome of intracytoplasmic 
sperm injection, Fertility and Sterility, 79, 42-8 
Devroey P, Godoy H, Smitz J et al. (1996) Female age predicts embryonic implantation after 
ICSI: a case controlled study. Human Reproduction, 11, 1324-1327 
European Society of Human Reproduction and Embryology (ESHRE) (2006) Three million 
babies born using assisted reproductive technologies. Press release at the 2006 
Annual Meeting  
Feldschuh J et al. (2005) Successful sperm storage for 28 years. Fertility and Sterility, 84,  
1017 
Franco JG, Baruffi RLR, Mauri AL et al. (2008) Significance of large nuclear vacuoles in 
human spermatozoa: implications for ICSI, Reproductive BioMedicine Online, 17(1), 
42-45 
Gillin-Smith C. et al. (2006) HIV and reproductive care – a review of current practice. British 
Journal of Gynaecology, 113, 869-878 
Gomez E, Perez-Cano I, Amorocho B et al. (2000) Effects of injected spermatozoa 
morphology on the outcome of intracytoplasmic sperm injection in humans. 
Fertility and Sterility, 74, 842-843 
Griffiths M, Kennedy CR, Rai J et al. (2004) Should cryopreserved epididymal or testicular 
sperm be recovered from obstructive azoospermic men for ICSI? BJOG, 111, 1289-
1293 
Hammadeh ME, Al-Hasani S, Stieber M et al. (1996) The effect of chromatin condensation 
(Aniline Blue staining) and morphology (strict criteria) of human spermatozoa on 
www.intechopen.com
 
Effectiveness of Assisted Reproduction Techniques as an Answer to Male Infertility 
 
127 
fertilization, cleavage and pregnancy rated in an intracytoplasmic sperm injection 
programme. Human Reproduction, 11, 2468-2471 
Handyside AH, Kontogianni EH, hardy K and Winston RM (1990) Pregnancies from 
biopsied human preimplantation embryos sexed by Y-specific DNA amplification, 
Nature, 344(6268), 768-770  
Hansen M, Bower C, Milne E et al. (2005) Assisted reproductive technologies and the risk of 
birth defects-a systematic review. Human Reproduction, 20(2), 328-338 
Harper JC, Coonen E, De Rycke M (2010) ESHRE PGD consortium data collection X: cycles 
from January to December 2007 with pregnancy followup, to October 2008, Human 
Reproduction, Vol.25, No.11 pp. 2685–2707 
Hazout A, Dumont-Hassan M, Junca AM et al. (2006) High-magnification ICSI overcomes 
paternal effect resistant to conventional ICSI. Reproductive BioMedicine Online 12, 
19–25.  
Helmerhost FM, Perquin DA, Donker D et al. (2004) Perinatal outcome of singletons and 
twins after assisted conception: a systematic review of controlled studies. BMJ, 
328(7434), 261. 
Hirsh AV, Mills C, Bekir J et al. (1994) Factors iinfluencing the outcome of in vitro 
fertilization with epididymal spermatozoa in irreversible obstructive azoospermia. 
Human Reproduction, 9, 1710-1716 
Holden CA, Fuscaldo GF, Jackson P et al. (1997) Frozen.thawed epididymal spermatozoa for 
intracytoplasmic sperm injection. Fertility and Sterility, 67, 81-87 
Human Fertilization and Embryology Authority (HFEA) (2005) The patient’s guide. 
London: HFEA 
Jackson RA, Gibson KA, Wu YW et al. (2004) Perinatal outcomes in singletons following  
in vitro fertilization: a meta-analysis. Obstetricts and Gynecology, 103(3), 551- 
563 
Jouannet P. et al. (1988) Male factors and the likelihood of pregnancy in infertile couples. I. 
Study of sperm characteristics. International Journal of Andrology, 11:379-394 
Kamischke A et al. (2004) Cryopreservation of sperm from adolescents and adults with 
malignancies. Journal of Andrology, 25, 586-592 
Larsen L et al. (2000) Computeur-assisted semen analysis parameters as predictors for 
fertility of men from the general population. The Danish First Pregnancy Planner 
Study Team. Human Reproduction, 15: 1562-1567 
Larson K, DeJonge C, Barnes A et al. (2000) Relationship of assisted reproductive technique 
(ART) outcomes with sperm chromatin integrity and maturity as measured  
by the sperm chromatin structure assay (SCSA). Human Reproduction 15, 1717– 
1722.  
Laws-King A, Trounson A, Sathananthan H et al. (1987) Fertilization of human oocytes by 
microinjection of single spermatozoa under the zona pellucida. Fertility and Sterility, 
48(4), 637-642 
Le Lannou D and Lansac J (1993) Artificial procreation with frozen donor semen: the French 
experience of CECOS. In: Barratt CLR, Cooke ID, eds. Donor insemination. 
Cambridge, Cambridge University Press: 152-169 
LudwigAK, Sutcliffe AG ,Dietrich K, Ludwig M (2006) Post-neonatal health and 
development of children born after assisted reproduction: a systematic review of 
www.intechopen.com
 
Male Infertility 
 
128 
controlled studies. European Journal of Obstetric Gynecology Reproductive Biology , 
127(1), 3-25 
Maduro MR, Casella R, Kim E et al. (2003) Microsatellite instability and defects in mismatch 
repair proteins: a new aetiology for Sertoli-cell-only syndrome. Molecular Human 
Reproduction, 9, 61-68 
Mansour RT, Aboulghar MA, Serour GI et al. (1996) Intracytoplasmic sperm injection using 
microsurgically retrieved epididymal and testicular sperm. Fertility and Sterility, 
65(3), 566-572 
Mak V and Jarvi KA (1996) The genetics of male infertility. Journal of Urology, 156, 1245- 
1256 
Mak V, Zielenski J, Tsui LC et al. (1999) Proportion of cystic fibrosis gene mutations not 
detected by routine testing in men with obstructive azoospermia. JAMA, 281, 2217-
2224 
Montanaro Gauci M, Kruger TF, Coetzee K et al. (2001) Stepwise regression analysis to study 
male and female factors impacting on pregnancy rate in an uterine insemination 
programme. Andrologia,33, 135-141  
Mortimer D (1994) Practical Laboratory Andrology. New York, NY: Oxford University 
Press. 
Mortimer D (2004) Current and future concepts and practices in human sperm cryobanking. 
Reproductive BioMedicine Online, 9, 134-151 
Nadalini M, Tarozzi N, Distratis V, Scaravelli G and Borini A (2009) Impact of 
intracytoplasmic morpholocically selected sperm injection on assisted reproduction 
outcome: a review. Reproductive BioMedicine Online, 19(3), 45-55 
Nagy ZP, Liu J, Joris H et al. (1995) The results of intracytoplasmic sperm injection is not 
related to any of the three basic sperm parameters. Human Reproduction, 10(5), 1123-
1129 
Nicopoullos JDM, Gilling-Smith C and Ramsay JWA (2004a) Does the cause of obstructive 
azoospermia affect the outcome of intracytoplasmic sperm injection: a meta-
analysis. BJU Int, 93, 1282-1286 
Nicopoullos JDM, Gilling-Smith C, Almeida PA et al. (2004b) Use of chirurgical  
sperm retrieval in azoospermic men: meta-analysis. Fertility and Sterility, 82, 691-
701 
Ombelet W, Vandeput H, Van de Putte G et al. (1997) Intrauterine insemination after ovarian 
stimulation with clomiphene citrate: predictive potential of inseminating motile 
count and sperm morphology, Human Reproduction, 12, 1458-1465 
Oehninger S, Acost AA, Morshedi M et al. (1988) Corrective measures and pregnancy 
outcome in in vitro fertilization in patients with severe sperm morphology 
abnormalities. Fertility and Sterility, 50, 283-287 
Oehninger S, Veeck L, Lanzendorf S et al. (1995) Intracytoplasmic sperm injection: 
Achievement of high pregnancy rates in couples with severe male factor infertility 
is dependent primarily upon female and not male factors. Fertility and Sterility, 64, 
977-981 
Pacheco SE, Andres Houseman E, Christensen BC, et al. (2011) Integrative DNA methylation 
and gene expression analyses identify DNA packaging and epigenetic regulatory 
genes associated with low motility sper. PLoS ONE, 6(6), e20280 
www.intechopen.com
 
Effectiveness of Assisted Reproduction Techniques as an Answer to Male Infertility 
 
129 
Pagani R, Brugh VMIII, Lamb DJ (2002) Chromosome and male infertility. The Urologic 
Clinics of North America, 29, 745-753 
Palermo G, Joris H, Devroey P et al. (1992) Pregnancies after intracytoplasmic sperm 
injection of single spermatozoa into an oocyte. Lancet, 340, 17-18 
Palermo G, Joris H, Derde MP et al. (1993) Sperm characteristics and outcome of human 
assisted fertilization by subzonal insemination and intracytoplasmic sperm 
injection. Fertility and Sterility, 63, 1231-1240 
Palermo GD, Alikani M, Bertoli M et al. (1996) Oolemma characteristics in relation to 
survival and fertilization patterns of oocytes treated by intracytoplasmic sperm 
injection. Human Reproduction, 11(1), 172-176 
Patrizio P (2000) Cryopreservation of epidydimal sperm. Molecular and Cellular 
Endocrinology, 27, 11-14 
Patsalis PC, Sismani C, Quintana-Murci L et al. (2002) Effects of transmission of Y 
chromosome AZFc deletions. Lancet, 360, 1222-4 
Polge C, Smith A and Parkes A (1949) Revival of spermatozoa after vitrification and 
dehydration at low temperature. Nature, 164, 666 
Ramos L, Wetzels AM, Hendriks JC et al. (2004) Percutaneous epididymal sperm aspiration: 
a diagnostic tool for the prediction of complete spermatogenesis. Reproductive 
BioMedicine Online, 8, 657-663 
Ranganathan P, Mahran AM, Hallak J and Agarwal A (2002) Sperm cryopreservation for 
men with nonmalignant, systemic diseases : a descriptive stidy. Journal of 
Andrology, 23, 71-75 
Rimm AA, Katayama AC, Diaz M et al. (2004) A meta-analysis of controlled studies 
comparing major malformation rates in IVF and ICSI infants with naturally 
conceived children. Journal of Assisted Reproduction and Genetics, 21(12), 437- 
443 
Rucker GB, Mielnik A, King P et al. (1998) Preoperative screening for genetic abnormalities 
in men with nonobstructive azoospermia before testicular sperm extraction. Journal 
of Urology, 160, 2068-2071 
Ryu HM, Lin WW, Lamb DJ et al. (2004) Increaesed chromosome X, Y, and 18 
nondisjunction in sperm from infertile patients that were identified as normal by 
strict morphology: implication for intracytoplasmic sperm injection. Fertility and 
Sterility, 76, 879-883 
Sacks PC and Simon JA (1991) Infectious complications of intrauterine insemination: a case 
report and literature review. International Journal of Fertility, 36, 331-339 
Savasi V. et al. (2007) Safety of sperm washing and ART outcome in 741 HIV-1-
serodiscordant couples. Human Reproduction, 22, 772-777 
Sbracia M, Grasso J, Stronk J and Huszar G (1997) Hyaluronic acid substantially increases 
the retention of motility in cryopreserved/thawed human spermatozoa. Human 
Reproduction,  12, 1949-1054 
Schlegel PN, Su LM and Li PS (1998) Gonadal sperm retrieval: potential for testicular 
damage in non-obstructive azoospermia. In Fillicori & C. Flamigni, eds. Treatment 
of Infertility: The new frontiers. New Jercy, NJ: Communications Media for 
Education, 383-392 
Schlegel PN (1999) Testicular sperm extraction; micro dissection improves sperm yield with 
minimal tissue excision. Human Reproduction, 14, 131-135 
www.intechopen.com
 
Male Infertility 
 
130 
Schyosman R, Vanderzwalmen P, Nijs M et al. (1993) Successful fertilization by testicular 
spermatozoa in an in vitro fertilization programme. Human Reproduction, 8(8), 1339-
1340 
Schmith KL, Larsen E, Bangsboll S et al. (2004) Assisted reproduction in male cancer 
survivors: fertility tretmant and outcome in 67 couples. Human Reproduction, 19, 
2806-2810 
Schover LR, Brey K, Lichtin A, Lipshultz LI and Jeha S (2002) Knowledge and experience 
regarding cancer, infertility, and sperm banking in younger male survivors. Journal 
of Clinical Oncology, 20, 1880-1889 
Schroeder-Printzen I, Zumbé J, Bispink L (2000) Microsurgical epididymal sperm aspiration: 
aspirate analysis and straws available after cryopreservation in patients with  
non-reconstructable obstructive azoospermia. Human Reproduction, 15, 2531- 
2535 
Sherman JK (1963) Improved methods of preservation of human spermatozoa by freezing 
and freeze-dying. Fertility and Sterility, 14, 49-64 
Sherman JK and Bunge RG (1953) Observation of preservation of human spermatozoa at 
low temperatures. Preceedings of the Society for Experimental Biology and Medicine. 
Society for Experimental Biology and Medicine,82, 686-688 
Shin D, Lo KC and Lipshultz LI (2005) Treatment options for infertile male with cancer. 
Journal of the National Cancer Institute Monographs, 34, 48-50 
Silber S, Ord T, Balmaceda J, Patrizio P and Asch RH (1990) Congenital absence of the vas 
deferens: studies on the fertilizing capacity of the human epididymal sperm. New 
England Jurnal of Medicine, 323, 1788-1792 
Silber S.J, Nagy ZP, Liu J et al. (1994) Conventional in vitro fertilization versus 
intracytoplasmic sperm injection for patients requiring microsurgical sperm 
aspiration. Human Reproduction, 9(9) 1705-1709 
Silber S.J, Van Steirteghem AC, Liu J et al. (1995) High fertilization and pregnancy rate after 
intracytoplasmic sperm injection with spermatozoa obtained from testicular 
biopsy. Human Reproduction, 10(1), 148-152 
Society for Assisted Reproductive Technology and Centers for Disease Control and 
Prevention (2004) ART success rates: national summary and fertility clinic reports. 
www.cdc.gov/reproductivehealth 
Staessen C and Van Steirteghem AC (1997) The chromosomal constitution of embryos 
developing from abnormal fertilized oocytes after intracytoplasmic sperm  
injection and conventional in vitro fertilization. Human Reproduction, 12(2), 321- 
327 
Staessen C, Tournaye H, Van Aasche E et al. (2003) PGD in 47,XXY Klineferter’s syndrome 
patients. Human Reproduction Update, 9, 319-330 
Steptoe PC and Edwards EG (1978) Birth after the re-implanted of a human embryo. Lancet, 
2, 366 
Svalander P, Jakobsson AH, Forsberg AS, Bengtsson AC, Wikland M (1996) The outcome of 
intracytoplasmic sperm injection is unrelated to “strict criteria” sperm morphology. 
Human Reproduction, 11, 1019-1022 
The European Parliament and the Council of the European Union  (2004) DIRECTIVE 
2004/23/EC OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 31 
March 2004 on setting standards of quality and safety for the donation, 
www.intechopen.com
 
Effectiveness of Assisted Reproduction Techniques as an Answer to Male Infertility 
 
131 
procurement, testing, processing, preservation, storage and distribution of human 
tissues and cells, Official Journal of the European Union, L 102/48-58 
Tournaye H, Devroey P, Liu J et al. (1994) Microsurgical epididymal sperm aspiration and 
intracytoplasmic sperm injection : a new effective approach to infertility as a result 
of congenital bilateral absence of the vas deferens. Fertility and Sterility, 61(6), 1045-
1051 
Tournaye H, Liu J, Nagy Z et al. (1996) The use of testicular sperm for intracytoplasmic 
sperm injection in patients with necrozoospermia. Fertility and Sterility, 66(2), 331-
334 
Van Steirteghem  AC, Liu J, Nagy Z et al. (1993a) Higher success rate by intracytoplasmic 
sperm injection than by subzonal insemination: report of a second series of 300 
consecutive treatment cycles. Human Reproduction, 8(7), 1055-1066 
Van Steirteghem  AC, Nagy Z, Joris H et al. (1993b) High fertilization and implantation  
rates after intracytoplasmic sperm injection. Human Reproduction, 8(7), 1061- 
1066 
Van Steirteghem  AC (2007) Assisted Fertilization. In vitro fertilization, a practical approach. 
Eds Informal Healtcare USA, Inc.  
Van Waart J, Kruger TF, Lombard CJ, Ombelet W (2001). Predictive value of normal sperm 
morphology in intrauterine insemination (IUI): a structural literature review. 
Human Reproduction Update, 7, 495-500 
Vanderzwalmen P, Hiemer A, Rubner P et al. (2008) Blastocyst development after sperm 
selection at high magnification is associated with size and number of nuclear 
vacuoles. Reproductive BioMedicine Online, 17(5), 617-627 
Wennerholm UB and Bergh C (2004) what is the most relevant standard of success in 
assisted reproduction? Singleton live births should also include preterm births. 
Human Reproduction, 19(9), 1943-1945 
Wilton LJ et al. (1988) Human male infertility caused by degeneration and deaths of sperms 
in the epididymis. Fertility and Sterility, 49, 1051-1058 
Wolf DP (1995) Semen cryopreservation. In: Keye WR et al., eds. Infertility evaluation and 
treatment. Philadelphia, WB Saunders, 686-695  
World Healt Organization (1987) WHO Laboratory Manual for the Examination of Human 
Semen and Sperm-Cervical Mucus Interaction. Cambridge University Press, 
Second edition. Cambridge. 
World Healt Organization (1992) WHO Laboratory Manual for the Examination of Human 
Semen and Sperm-Cervical Mucus Interaction. Cambridge University Press, Third 
edition. Cambridge. 
World Healt Organization (2010) WHO Laboratory Manual for the Examination and 
Processing of Human Semen. Cambridge University Press, Fifth edition. 
Cambridge. 
Yalti S, Gurbuz B, Sezer H, Celik S (2004) Effects of semen characteristics on IUI combined 
with mild ovarian stimulation, Arch Androl, 50(4), 239-246 
Yeung CH, Cooper TG, Nieschlag E (1997) A technique for standardization and quality 
control of subjective sperm motility assessment in semen analysis, Fertility and 
Sterility, 67, 1156-1158  
Yoshida A, Miura K, Shirai M (1997) Cytogenetic survey of 1007 infertilt males. International 
Journal of Urology, 58, 166-76 
www.intechopen.com
 
Male Infertility 
 
132 
Yoshida KI, Yano M, Chiba K , Honda M, Kitahara S (1999) CAG repeat length in the 
androgen receoptor gene is enhanced in patients with idiopathic azoospermia, 
Urology, 54, 1078-1081 
Zinaman MJ et al. (2000) Semen quality and human fertility: a prospective study with 
healthy couples. Journal of Andrology, 21: 145-153 
www.intechopen.com
Male Infertility
Edited by Dr. Anu Bashamboo
ISBN 978-953-51-0562-6
Hard cover, 194 pages
Publisher InTech
Published online 20, April, 2012
Published in print edition April, 2012
InTech Europe
University Campus STeP Ri 
Slavka Krautzeka 83/A 
51000 Rijeka, Croatia 
Phone: +385 (51) 770 447 
Fax: +385 (51) 686 166
www.intechopen.com
InTech China
Unit 405, Office Block, Hotel Equatorial Shanghai 
No.65, Yan An Road (West), Shanghai, 200040, China 
Phone: +86-21-62489820 
Fax: +86-21-62489821
Male infertility is a multifaceted disease where genetic, epigenetic and environmental factors all contribute to
the development of the phenotype. In recent years, there has been an increasing concern about a decline in
reproductive health, paralleled by an increase in demand for infertility treatments. This calls for a detailed and
thorough understanding of normal and aberrant testicular function and the environmental influences on the
establishment and integrity of the male germ cell. This is crucial for understanding the complex
pathophysiology of male infertility and eventual success of Assisted Reproductive Technologies.
How to reference
In order to correctly reference this scholarly work, feel free to copy and paste the following:
Sandrine Chamayou and Antonino Guglielmino (2012). Effectiveness of Assisted Reproduction Techniques as
an Answer to Male Infertility, Male Infertility, Dr. Anu Bashamboo (Ed.), ISBN: 978-953-51-0562-6, InTech,
Available from: http://www.intechopen.com/books/male-infertility/effectiveness-of-assisted-reproductive-
techniques-as-an-answer-to-male-infertility
© 2012 The Author(s). Licensee IntechOpen. This is an open access article
distributed under the terms of the Creative Commons Attribution 3.0
License, which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.
